129 related articles for article (PubMed ID: 34397724)
21. Pleural IFN-γ release assay combined with biomarkers distinguished effectively tuberculosis from malignant pleural effusion.
Tang Y; Zhang J; Huang H; He X; Zhang J; Ou M; Li G; Zeng C; Ye T; Ren L; Liu Y; Zhang G
BMC Infect Dis; 2019 Jan; 19(1):55. PubMed ID: 30651075
[TBL] [Abstract][Full Text] [Related]
22. A meta-analysis of Th1 and Th2 cytokine profiles differentiating tuberculous from malignant pleural effusion.
Zeng Y; Wang L; Zhou H; Qi Y
Sci Rep; 2022 Feb; 12(1):2743. PubMed ID: 35177742
[TBL] [Abstract][Full Text] [Related]
23. Different characteristics of pleural abnormalities on computed tomography between tuberculous and malignant pleural effusions.
Lee J; Park J; Park JE; Lee YH; Choi SH; Seo H; Yoo SS; Lee SY; Cha SI; Park JY; Lim JK; Kim CH
Am J Med Sci; 2023 Jul; 366(1):57-63. PubMed ID: 37105238
[TBL] [Abstract][Full Text] [Related]
24. Determination of Interleukin 27-Producing CD4(+) and CD8(+) T Cells for The Differentiation Between Tuberculous and Malignant Pleural Effusions.
Liu YL; Wu YB; Zhai K; Wang XJ; Shi HZ
Sci Rep; 2016 Jan; 6():19424. PubMed ID: 26783266
[TBL] [Abstract][Full Text] [Related]
25. Proinflammatory cytokines and fibrinolytic enzymes in tuberculous and malignant pleural effusions.
Hua CC; Chang LC; Chen YC; Chang SC
Chest; 1999 Nov; 116(5):1292-6. PubMed ID: 10559090
[TBL] [Abstract][Full Text] [Related]
26. Potential biomarkers for antidiastole of tuberculous and malignant pleural effusion by proteome analysis.
Shi J; Li P; Zhou L; Qi S; Wang B; Li D; Duan L; Chen WX; Xia J; Zou L; Yang S
Biomark Med; 2019 Feb; 13(2):123-133. PubMed ID: 30791695
[TBL] [Abstract][Full Text] [Related]
27. A simple C-reactive protein measurement for the differentiation between tuberculous and malignant pleural effusion.
Chierakul N; Kanitsap A; Chaiprasert A; Viriyataveekul R
Respirology; 2004 Mar; 9(1):66-9. PubMed ID: 14982604
[TBL] [Abstract][Full Text] [Related]
28. The impact of expressions of CD97 and its ligand CD55 at the invasion front on prognosis of rectal adenocarcinoma.
Han SL; Xu C; Wu XL; Li JL; Liu Z; Zeng QQ
Int J Colorectal Dis; 2010 Jun; 25(6):695-702. PubMed ID: 20339853
[TBL] [Abstract][Full Text] [Related]
29. Atypical Pleural Fluid Profiles in Tuberculous Pleural Effusion: Sequential Changes Compared with Parapneumonic and Malignant Pleural Effusions.
Kim CH; Lee SY; Lee YD; Yoo SS; Lee SY; Cha SI; Park JY; Lee J
Intern Med; 2016; 55(13):1713-9. PubMed ID: 27374670
[TBL] [Abstract][Full Text] [Related]
30. Role of cancer ratio and other new parameters in the differential diagnosis of malignant pleural effusion.
Ren Z; Xu L
Clinics (Sao Paulo); 2021; 76():e2515. PubMed ID: 33909825
[TBL] [Abstract][Full Text] [Related]
31. Combined detections of interleukin 27, interferon-γ, and adenosine deaminase in pleural effusion for diagnosis of tuberculous pleurisy.
Wu YB; Ye ZJ; Qin SM; Wu C; Chen YQ; Shi HZ
Chin Med J (Engl); 2013; 126(17):3215-21. PubMed ID: 24033939
[TBL] [Abstract][Full Text] [Related]
32. Expression and prognostic value of soluble CD97 and its ligand CD55 in intrahepatic cholangiocarcinoma.
Meng ZW; Liu MC; Hong HJ; Du Q; Chen YL
Tumour Biol; 2017 Mar; 39(3):1010428317694319. PubMed ID: 28345461
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic value of interleukin 22 and carcinoembryonic antigen in tuberculous and malignant pleural effusions.
Jin D; Chen Y; Wang Z; Wang S; Bunjhoo H; Zhu J; Cao Y; Xiong W; Xiong S; Xu Y; Fang H
Exp Ther Med; 2011 Nov; 2(6):1205-1209. PubMed ID: 22977645
[TBL] [Abstract][Full Text] [Related]
34. Novel clinical biomarkers in blood and pleural effusion for diagnosing patients with tuberculosis distinguishing from malignant tumor.
Wang J; Feng ZX; Ren T; Meng WY; Khan I; Fan XX; Pan HD; Liu L; Tang YJ; Yao XJ; Li RZ; Wang MF; Leung EL
Medicine (Baltimore); 2022 Oct; 101(41):e31027. PubMed ID: 36254028
[TBL] [Abstract][Full Text] [Related]
35. Differences in
Xie T; Wang Q; Gao J; He K; Yu J
Ann Clin Lab Sci; 2024 Mar; 54(2):201-210. PubMed ID: 38802158
[TBL] [Abstract][Full Text] [Related]
36. S100A2: A potential biomarker to differentiate malignant from tuberculous pleural effusion.
Wang T; Wang N; Zhang L; Liu Y; Thakur A
Indian J Cancer; 2021; 58(2):241-247. PubMed ID: 33402562
[TBL] [Abstract][Full Text] [Related]
37. Role of CD97(stalk) and CD55 as molecular markers for prognosis and therapy of gastric carcinoma patients.
Liu Y; Chen L; Peng SY; Chen ZX; Hoang-Vu C
J Zhejiang Univ Sci B; 2005 Sep; 6(9):913-8. PubMed ID: 16130195
[TBL] [Abstract][Full Text] [Related]
38. Adenosine deaminase activity level as a tool for diagnosing tuberculous pleural effusion.
Khow-Ean N; Booraphun S; Aekphachaisawat N; Sawanyawisuth K
Southeast Asian J Trop Med Public Health; 2013 Jul; 44(4):655-9. PubMed ID: 24050100
[TBL] [Abstract][Full Text] [Related]
39. Discriminating Tuberculous Pleural Effusion from Malignant Pleural Effusion Based on Routine Pleural Fluid Biomarkers, Using Mathematical Methods.
Darooei R; Sanadgol G; Gh-Nataj A; Almasnia M; Darivishi A; Eslaminejad A; Raoufy MR
Tanaffos; 2017; 16(2):157-165. PubMed ID: 29308081
[TBL] [Abstract][Full Text] [Related]
40. High-throughput autoantibody analysis in malignant pleural effusion and tuberculosis pleural effusion.
Yi F; Zhang X
Medicine (Baltimore); 2019 Sep; 98(38):e17253. PubMed ID: 31567996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
